Evidence map›Paper›PMID 21478852›Full record

ReviewNature biotechnology2011

Overcoming barriers to membrane protein structure determination.

Roslyn M Bill, Peter J F Henderson, So Iwata, Edmund R S Kunji, Hartmut Michel, Richard Neutze, Simon Newstead, Bert Poolman, Christopher G Tate, Horst Vogel

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature biotechnology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 146 papers.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

146 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Future opportunities in solute carrier structural biology.Nature structural & molecular biology · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. How can we discover developable antibody-based biotherapeutics?Frontiers in molecular biosciences · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. BBA advances · 2022
    Article
  19. Article
  20. Article

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Roslyn M BillSchool of Life and Health Sciences, Aston University, Birmingham, UK.
Peter J F Henderson
So Iwata
Edmund R S Kunji
Hartmut Michel
Richard Neutze
Simon Newstead
Bert Poolman
Christopher G Tate
Horst Vogel

Funding

Biotechnology and Biological Sciences Research Council B17935Biotechnology and Biological Sciences Research Council BB/D524832/1Biotechnology and Biological Sciences Research Council BB/G020043/1Medical Research Council MC_U105197215Medical Research Council MC_U105663139
6 · The paper itself

Abstract

After decades of slow progress, the pace of research on membrane protein structures is beginning to quicken thanks to various improvements in technology, including protein engineering and microfocus X-ray diffraction. Here we review these developments and, where possible, highlight generic new approaches to solving membrane protein structures based on recent technological advances. Rational approaches to overcoming the bottlenecks in the field are urgently required as membrane proteins, which typically comprise ~30% of the proteomes of organisms, are dramatically under-represented in the structural database of the Protein Data Bank.

Indexed as

Protein Structure, TertiaryX-Ray DiffractionCrystallizationDatabases, ProteinMembrane ProteinsProtein EngineeringProtein StabilityProtein UnfoldingRecombinant ProteinsMembrane ProteinsRecombinant Proteins

Identifiers

PMID21478852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.